Company Info
Phone(617) 349-1971
Year Established
2008
Ticker
BCRX
Exchange
NASDAQ
Contacts
Andrew A. KomjathyCCO
Company Description
Astria Therapeutics, a BioCryst Pharmaceuticals company, lead program, STAR-0215, is in preclinical development to treat Hereditary Angioedema, a rare genetic disorder.